Ken Kersemans
work address
Nucleaire geneeskunde C. Heymanslaan 10
9000 Gent
9000 Gent
1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
- [18F]-FET and [18F]-FAZA PET guided irradiation of glioblastoma in rats
- 2017
- In vitro characterization of the amino acid PET tracer 2-[18F]FELP and in vivo comparison to [18F]FET and [18F]FDG in a F98 glioblastoma rat model
- In vitro and in vivo evaluation of the LAT1 PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG
- Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid, a radiolabeled bile acid to detect drug-induced cholestasis in preclinical drug development.
- Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice
- 2016
- Evaluation of the LAT1 selective amino acid PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG in a F98 glioblastoma rat model
- Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function
- Gelatin- and starch-based hydrogels, part A : hydrogel development, characterization and coating
- In vivo evaluation of blood based and reference tissue based PET quantifications of [11C]DASB in the canine brain